HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J H Stone Selected Research

Systemic Vasculitis

10/2007Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).
6/2001New approaches to treatment in systemic vasculitis: biological therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J H Stone Research Topics

Disease

10Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2017 - 08/2000
7Vasculitis (Vasculitides)
06/2015 - 12/2000
6Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2017 - 12/2000
4Microscopic Polyangiitis
01/2017 - 12/2000
3Immunoglobulin G4-Related Disease
07/2019 - 03/2014
2Infections
01/2017 - 08/2001
2Disease Progression
06/2015 - 08/2000
2Churg-Strauss Syndrome (Allergic Angiitis)
10/2007 - 12/2000
2Systemic Vasculitis
10/2007 - 06/2001
1Asthma (Bronchial Asthma)
01/2021
1Eosinophilia
03/2014
1Phlebitis
03/2014
1Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
11/2012
1Takayasu Arteritis (Arteritis, Takayasu's)
11/2012
1Giant Cell Arteritis (Horton Disease)
11/2012
1Autoimmune Diseases (Autoimmune Disease)
01/2009
1Inflammation (Inflammations)
10/2007
1Neoplasms (Cancer)
11/2001
1Necrosis
06/2001
1Injection Site Reaction
05/2001
1Glomerulonephritis
12/2000

Drug/Important Bio-Agent (IBA)

8Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2017 - 12/2000
3GlucocorticoidsIBA
01/2021 - 06/2015
3Rituximab (Mabthera)FDA Link
06/2015 - 09/2013
2ImmunosorbentsIBA
01/2017 - 12/2000
2AntibodiesIBA
01/2017 - 10/2007
2Myeloblastin (Proteinase 3)IBA
01/2017 - 01/2009
2EnzymesIBA
01/2017 - 12/2000
2Prednisone (Sone)FDA LinkGeneric
06/2015 - 09/2013
2AntigensIBA
01/2009 - 10/2007
1RNA (Ribonucleic Acid)IBA
07/2019
1Immunoglobulins (Immunoglobulin)IBA
01/2017
1Immunoglobulin M (IgM)IBA
01/2017
1Peptide Hydrolases (Proteases)FDA Link
06/2015
1Immunoglobulin G (IgG)IBA
03/2014
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2013
1Azathioprine (Imuran)FDA LinkGeneric
09/2013
1tocilizumab (atlizumab)FDA Link
11/2012
1Interleukin-6 (Interleukin 6)IBA
11/2012
1AutoantigensIBA
01/2009
1Prostaglandins AIBA
01/2009
1CarbohydratesIBA
01/2009
1Peroxidase (Myeloperoxidase)IBA
10/2007
1Serine Proteases (Serine Protease)IBA
10/2007
1VancomycinFDA LinkGeneric
08/2001
1CytokinesIBA
06/2001
1Biological ProductsIBA
06/2001
1Interferon-gamma (Interferon, gamma)IBA
06/2001
1Etanercept (Enbrel)FDA Link
05/2001

Therapy/Procedure

5Therapeutics
09/2016 - 08/2000
1Remission Induction
09/2013
1Drug Therapy (Chemotherapy)
11/2001
1Immunotherapy
06/2001
1Biological Therapy
06/2001
1Injections
05/2001